Skip to main content
Loading

Cell Therapy Manufacturing Topic: Standardizing flow cytometry and QA across cell therapy development and manufacturing

08 Sept 2026
Gene Therapy Development
  • What are the key bottlenecks in cell therapy development, and in transferring products to manufacturing?  
  • How are teams using flow cytometry across development and manufacturing processes for cell therapies?  
  • What sources of assay variation impact cell therapy development?
  • How could standardized synthetic controls enable more automated approaches to flow cytometry, reduce bridging studies, and improve multisite harmonization?   
Industry Expert
Kristin Lind, Technical Product Manager - Slingshot Biosciences